{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T04:59:33Z","timestamp":1792299573469,"version":"4.4.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T00:00:00Z","timestamp":1676332800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81873791"],"award-info":[{"award-number":["81873791"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82122022"],"award-info":[{"award-number":["82122022"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82171248"],"award-info":[{"award-number":["82171248"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82230084"],"award-info":[{"award-number":["82230084"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006407","name":"Henan Province Natural Science Foundation","doi-asserted-by":"publisher","award":["202300410357"],"award-info":[{"award-number":["202300410357"]}],"id":[{"id":"10.13039\/501100006407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.eclinm.2023.101888","type":"journal-article","created":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T20:33:02Z","timestamp":1679085182000},"page":"101888","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Efficacy of faecal microbiota transplantation in patients with progressive supranuclear palsy-Richardson's syndrome: a phase 2, single centre, randomised clinical trial"],"prefix":"10.1016","volume":"58","author":[{"given":"Haiyan","family":"Tian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiuqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renyi","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongkang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongxiao","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanping","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingjing","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junfang","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuebing","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.eclinm.2023.101888_bib1","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S1474-4422(17)30157-6","article-title":"Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches","volume":"16","author":"Boxer","year":"2017","journal-title":"Lancet Neurol"},{"issue":"18","key":"10.1016\/j.eclinm.2023.101888_bib2","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1212\/WNL.0000000000002638","article-title":"Prevalence, characteristics, and survival of frontotemporal lobar degeneration syndromes","volume":"86","author":"Coyle-Gilchrist","year":"2016","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.eclinm.2023.101888_bib3","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/mds.26987","article-title":"Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria","volume":"32","author":"Hoglinger","year":"2017","journal-title":"Mov Disord"},{"issue":"3","key":"10.1016\/j.eclinm.2023.101888_bib4","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S1474-4422(09)70042-0","article-title":"Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges","volume":"8","author":"Williams","year":"2009","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.1016\/j.eclinm.2023.101888_bib5","first-page":"3","article-title":"Clinical approach to progressive supranuclear palsy","volume":"9","author":"Ling","year":"2016","journal-title":"J\u00a0Mov Disord"},{"issue":"5","key":"10.1016\/j.eclinm.2023.101888_bib6","first-page":"61","article-title":"The differential diagnosis and treatment of atypical parkinsonism","volume":"113","author":"Levin","year":"2016","journal-title":"Dtsch Arztebl Int"},{"issue":"Pt 6","key":"10.1016\/j.eclinm.2023.101888_bib7","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1093\/brain\/awm032","article-title":"A\u00a0clinical rating scale for progressive supranuclear palsy","volume":"130","author":"Golbe","year":"2007","journal-title":"Brain"},{"issue":"Pt 5","key":"10.1016\/j.eclinm.2023.101888_bib8","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1093\/brain\/awn065","article-title":"Clinical outcomes of progressive supranuclear palsy and multiple system atrophy","volume":"131","author":"O'Sullivan","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.eclinm.2023.101888_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105314","article-title":"The impact of the microbiota-gut-brain axis on Alzheimer's disease pathophysiology","volume":"164","author":"Doifode","year":"2021","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.eclinm.2023.101888_bib10","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.arr.2018.04.004","article-title":"Dysbiosis of gut microbiota and microbial metabolites in Parkinson's Disease","volume":"45","author":"Sun","year":"2018","journal-title":"Ageing Res Rev"},{"issue":"10","key":"10.1016\/j.eclinm.2023.101888_bib11","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1007\/s11427-016-5083-9","article-title":"Alzheimer's disease and gut microbiota","volume":"59","author":"Hu","year":"2016","journal-title":"Sci China Life Sci"},{"issue":"2","key":"10.1016\/j.eclinm.2023.101888_bib12","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1001\/jama.2018.20046","article-title":"Effect of fecal microbiota transplantation on 8-week remission in patients with ulcerative colitis: a randomized clinical trial","volume":"321","author":"Costello","year":"2019","journal-title":"JAMA"},{"issue":"26","key":"10.1016\/j.eclinm.2023.101888_bib13","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1056\/NEJMc1803103","article-title":"Fecal microbiota transplantation for primary Clostridium difficile infection","volume":"378","author":"Juul","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.eclinm.2023.101888_bib14","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41531-017-0037-x","article-title":"Non motor symptoms in progressive supranuclear palsy: prevalence and severity","volume":"3","author":"Radicati","year":"2017","journal-title":"NPJ Parkinsons Dis"},{"key":"10.1016\/j.eclinm.2023.101888_bib15","article-title":"Characteristics of nonmotor symptoms in progressive supranuclear palsy","volume":"2016","author":"Ou","year":"2016","journal-title":"Parkinsons Dis"},{"issue":"14","key":"10.1016\/j.eclinm.2023.101888_bib16","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1002\/mds.22289","article-title":"Autonomic dysfunction in patients with progressive supranuclear palsy","volume":"23","author":"Schmidt","year":"2008","journal-title":"Mov Disord"},{"issue":"3","key":"10.1016\/j.eclinm.2023.101888_bib17","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/mds.27581","article-title":"Unraveling gut microbiota in Parkinson's disease and atypical parkinsonism","volume":"34","author":"Barichella","year":"2019","journal-title":"Mov Disord"},{"key":"10.1016\/j.eclinm.2023.101888_bib18","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.neulet.2018.12.031","article-title":"Tau immunoreactivity in peripheral tissues of human aging and select tauopathies","volume":"696","author":"Dugger","year":"2019","journal-title":"Neurosci Lett"},{"issue":"1","key":"10.1016\/j.eclinm.2023.101888_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/WNL.47.1.1","article-title":"Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop","volume":"47","author":"Litvan","year":"1996","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.eclinm.2023.101888_bib20","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1093\/cid\/civ994","article-title":"Establishing a fecal microbiota transplant service for the treatment of Clostridium difficile infection","volume":"62","author":"Costello","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.eclinm.2023.101888_bib50","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1136\/gutjnl-2016-313017","article-title":"European consensus conference on faecal microbiota transplantation in clinical practice","volume":"66","author":"Cammarota","year":"2017","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.eclinm.2023.101888_bib21","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s40168-019-0683-9","article-title":"Alterations in the gut microbiome and metabolism with coronary artery disease severity","volume":"7","author":"Liu","year":"2019","journal-title":"Microbiome"},{"issue":"5","key":"10.1016\/j.eclinm.2023.101888_bib22","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nmeth.f.303","article-title":"QIIME allows analysis of high-throughput community sequencing data","volume":"7","author":"Caporaso","year":"2010","journal-title":"Nat Methods"},{"issue":"5","key":"10.1016\/j.eclinm.2023.101888_bib23","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/mds.26580","article-title":"Power calculations and placebo effect for future clinical trials in progressive supranuclear palsy","volume":"31","author":"Stamelou","year":"2016","journal-title":"Mov Disord"},{"issue":"1","key":"10.1016\/j.eclinm.2023.101888_bib24","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s40168-021-01103-z","article-title":"The microbial metabolite p-Cresol induces autistic-like behaviors in mice by remodeling the gut microbiota","volume":"9","author":"Bermudez-Martin","year":"2021","journal-title":"Microbiome"},{"issue":"1","key":"10.1016\/j.eclinm.2023.101888_bib25","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12974-019-1434-3","article-title":"Impact of microbiota on central nervous system and neurological diseases: the gut-brain axis","volume":"16","author":"Ma","year":"2019","journal-title":"J\u00a0Neuroinflammation"},{"issue":"2","key":"10.1016\/j.eclinm.2023.101888_bib26","first-page":"118","article-title":"The non-motor symptom profile of progressive supranuclear palsy","volume":"13","author":"Chaithra","year":"2020","journal-title":"J\u00a0Mov Disord"},{"key":"10.1016\/j.eclinm.2023.101888_bib27","article-title":"Gallic acid alleviates gut dysfunction and boosts immune and antioxidant activities in puppies under environmental stress based on microbiome-metabolomics analysis","volume":"12","author":"Yang","year":"2021","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.eclinm.2023.101888_bib28","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41531-022-00328-5","article-title":"Short chain fatty acids-producing and mucin-degrading intestinal bacteria predict the progression of early Parkinson's disease","volume":"8","author":"Nishiwaki","year":"2022","journal-title":"NPJ Parkinsons Dis"},{"key":"10.1016\/j.eclinm.2023.101888_bib29","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.pharmthera.2016.04.007","article-title":"Benefits of short-chain fatty acids and their receptors in inflammation and carcinogenesis","volume":"164","author":"Sivaprakasam","year":"2016","journal-title":"Pharmacol Ther"},{"issue":"8","key":"10.1016\/j.eclinm.2023.101888_bib30","doi-asserted-by":"crossref","first-page":"e848","DOI":"10.1212\/WNL.0000000000013225","article-title":"Association of fecal and plasma levels of short-chain fatty acids with gut microbiota and clinical severity in patients with Parkinson disease","volume":"98","author":"Chen","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.eclinm.2023.101888_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.844564","article-title":"Bi-directionality of the microbiota-gut-brain Axis in patients with functional dyspepsia: relevance of psychotherapy and probiotics","volume":"16","author":"Rupp","year":"2022","journal-title":"Front Neurosci"},{"issue":"5","key":"10.1016\/j.eclinm.2023.101888_bib32","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-043959","article-title":"Intestinal barrier function in obesity with or without metabolic syndrome: a systematic review protocol","volume":"11","author":"Bona","year":"2021","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.eclinm.2023.101888_bib33","article-title":"Irritable bowel syndrome between molecular approach and clinical expertise-searching for gap fillers in the oxidative stress way of thinking","volume":"56","author":"Balmus","year":"2020","journal-title":"Medicina (Kaunas)"},{"issue":"9","key":"10.1016\/j.eclinm.2023.101888_bib34","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1002\/jcp.25518","article-title":"Neurotransmitters: the critical modulators regulating gut-brain Axis","volume":"232","author":"Mittal","year":"2017","journal-title":"J\u00a0Cell Physiol"},{"issue":"5","key":"10.1016\/j.eclinm.2023.101888_bib35","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1053\/j.gastro.2018.12.001","article-title":"Specific bacteria and metabolites associated with response to fecal microbiota transplantation in patients with ulcerative colitis","volume":"156","author":"Paramsothy","year":"2019","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.eclinm.2023.101888_bib36","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1053\/j.gastro.2015.04.001","article-title":"Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial","volume":"149","author":"Moayyedi","year":"2015","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.eclinm.2023.101888_bib37","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1136\/gutjnl-2019-319630","article-title":"Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study","volume":"69","author":"El-Salhy","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.eclinm.2023.101888_bib38","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.bbi.2018.02.005","article-title":"Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson's disease mice: gut microbiota, glial reaction and TLR4\/TNF-alpha signaling pathway","volume":"70","author":"Sun","year":"2018","journal-title":"Brain Behav Immun"},{"issue":"1","key":"10.1016\/j.eclinm.2023.101888_bib39","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/s40168-021-01107-9","article-title":"Fecal microbiota transplantation protects rotenone-induced Parkinson's disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis","volume":"9","author":"Zhao","year":"2021","journal-title":"Microbiome"},{"issue":"2","key":"10.1016\/j.eclinm.2023.101888_bib40","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1136\/gutjnl-2018-317431","article-title":"Transfer of a healthy microbiota reduces amyloid and tau pathology in an Alzheimer's disease animal model","volume":"69","author":"Kim","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.eclinm.2023.101888_bib41","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.bbi.2021.09.002","article-title":"Transplantation of gut microbiota derived from Alzheimer's disease mouse model impairs memory function and neurogenesis in C57BL\/6 mice","volume":"98","author":"Kim","year":"2021","journal-title":"Brain Behav Immun"},{"issue":"7698","key":"10.1016\/j.eclinm.2023.101888_bib42","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nature25979","article-title":"Extensive impact of non-antibiotic drugs on human gut bacteria","volume":"555","author":"Maier","year":"2018","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.eclinm.2023.101888_bib43","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1136\/gutjnl-2019-320204","article-title":"Interaction between drugs and the gut microbiome","volume":"69","author":"Weersma","year":"2020","journal-title":"Gut"},{"issue":"8","key":"10.1016\/j.eclinm.2023.101888_bib44","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1038\/s41591-021-01455-x","article-title":"Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trial","volume":"27","author":"Dam","year":"2021","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.eclinm.2023.101888_bib45","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S1474-4422(20)30489-0","article-title":"Safety and efficacy of tilavonemab in progressive supranuclear palsy: a phase 2, randomised, placebo-controlled trial","volume":"20","author":"Hoglinger","year":"2021","journal-title":"Lancet Neurol"},{"issue":"2","key":"10.1016\/j.eclinm.2023.101888_bib46","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s13238-016-0338-6","article-title":"Human gut microbiota: the links with dementia development","volume":"8","author":"Alkasir","year":"2017","journal-title":"Protein Cell"},{"issue":"9","key":"10.1016\/j.eclinm.2023.101888_bib47","doi-asserted-by":"crossref","DOI":"10.3390\/nu13093211","article-title":"Effects and mechanisms of probiotics, prebiotics, synbiotics, and postbiotics on metabolic diseases targeting gut microbiota: a narrative review","volume":"13","author":"Li","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.eclinm.2023.101888_bib48","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3389\/fvets.2015.00057","article-title":"Regulation of the intestinal barrier function by host defense peptides","volume":"2","author":"Robinson","year":"2015","journal-title":"Front Vet Sci"},{"issue":"12","key":"10.1016\/j.eclinm.2023.101888_bib49","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1007\/s00125-010-1903-9","article-title":"Restoration of impaired intestinal barrier function by the hydrolysed casein diet contributes to the prevention of type 1 diabetes in the diabetes-prone BioBreeding rat","volume":"53","author":"Visser","year":"2010","journal-title":"Diabetologia"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537023000652?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537023000652?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:19:33Z","timestamp":1762899573000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537023000652"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":50,"alternative-id":["S2589537023000652"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2023.101888","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of faecal microbiota transplantation in patients with progressive supranuclear palsy-Richardson's syndrome: a phase 2, single centre, randomised clinical trial","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2023.101888","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101888"}}